Updates to the Perinatal Guidelines and the Adult and Adolescent OI Guidelines

May 6, 2016

The Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States (Perinatal Guidelines) were updated on April 29, 2016. In this revision:

  1. Table 7: Antiretroviral Drug Use in Pregnant HIV-Infected Women: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy was revised.
  2. The abacavir, etravirine, and didanosine sections were updated to include new data and publications, including Food and Drug Administration label updates.
  3. The amprenavir, delavirdine, and zalcitabine sections were removed from the guidelines as the drugs are no longer available in the United States. Additional information on these drugs can be found in the archived Perinatal Guidelines

Additionally, the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents were updated on May 3, 2016. In this revision, the Bacterial Enteric Infections section was updated to include new information on the growing issue of antibiotic resistance among enteric bacteria, as well as updated information on the treatment of enteric infections, including in pregnant women.

Related Stories

Read the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (PDF)
What Did You Expect While You Were Expecting?
HIV/AIDS Resource Center for Women

This article was provided by AIDSinfo. Visit the AIDSinfo website to find out more about their activities and publications.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.